Загрузка...
Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial
INTRODUCTION: The recent CONCEPT study showed that 800 mg/day of pharmaceutical-grade chondroitin sulfate (CS) was superior to placebo and similar to celecoxib in reducing pain and improving function over 6 months in patients with symptomatic knee osteoarthritis (OA). We investigate, in the present...
Сохранить в:
| Опубликовано в: : | Adv Ther |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Healthcare
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547984/ https://ncbi.nlm.nih.gov/pubmed/32954487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01484-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|